ClinicalTrials.gov record
A Study Of Sunitinib In Combination With Capecitabine Compared With Capecitabine In Patients With Breast Cancer
ClinicalTrials.gov ID: NCT00435409
Public ClinicalTrials.gov record NCT00435409. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Phase 3 Study Of Sunitinib In Combination With Capecitabine Compared With Capecitabine In Patients With Previously Treated Breast Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The treatment received with sunitinib plus capecitabine could delay tumor growth longer than with treatment with capecitabine alone.
Study identification
- NCT ID
- NCT00435409
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 442 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2007 (Type not available)
- Primary completion
- Dec 2009 (Actual)
- Completion
- Jun 2011 (Actual)
- Last update posted
- Jun 26, 2012
2007 – 2011
United States locations
- U.S. sites
- 79
- U.S. states
- 18
- U.S. cities
- 59
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Downey | California | 90241 | — |
| Pfizer Investigational Site | Fresno | California | 93720 | — |
| Pfizer Investigational Site | Montebello | California | 90640 | — |
| Pfizer Investigational Site | Whittier | California | 90606 | — |
| Pfizer Investigational Site | Boca Raton | Florida | 33428 | — |
| Pfizer Investigational Site | Boynton Beach | Florida | 33437 | — |
| Pfizer Investigational Site | Coral Springs | Florida | 33065 | — |
| Pfizer Investigational Site | Hollywood | Florida | 33021 | — |
| Pfizer Investigational Site | Lake Worth | Florida | 33467 | — |
| Pfizer Investigational Site | Lakeland | Florida | 33805 | — |
| Pfizer Investigational Site | Miami | Florida | 33125 | — |
| Pfizer Investigational Site | Miami | Florida | 33129 | — |
| Pfizer Investigational Site | Miami | Florida | 33133 | — |
| Pfizer Investigational Site | Pembroke Pines | Florida | 33028 | — |
| Pfizer Investigational Site | Duluth | Georgia | 30096 | — |
| Pfizer Investigational Site | Lawrenceville | Georgia | 30045 | — |
| Pfizer Investigational Site | Snellville | Georgia | 30078 | — |
| Pfizer Investigational Site | Avon | Indiana | 46123 | — |
| Pfizer Investigational Site | Indianapolis | Indiana | 46260 | — |
| Pfizer Investigational Site | Mooresville | Indiana | 46158 | — |
| Pfizer Investigational Site | Covington | Louisiana | 70433 | — |
| Pfizer Investigational Site | Gretna | Louisiana | 70056 | — |
| Pfizer Investigational Site | Marrero | Louisiana | 70072 | — |
| Pfizer Investigational Site | Metairie | Louisiana | 70002 | — |
| Pfizer Investigational Site | Metairie | Louisiana | 70006 | — |
| Pfizer Investigational Site | New Orleans | Louisiana | 70115 | — |
| Pfizer Investigational Site | Shreveport | Louisiana | 71103 | — |
| Pfizer Investigational Site | Kensington | Maryland | 20895 | — |
| Pfizer Investigational Site | Rockville | Maryland | 20850 | — |
| Pfizer Investigational Site | Corinth | Mississippi | 38834 | — |
| Pfizer Investigational Site | Columbia | Missouri | 65201 | — |
| Pfizer Investigational Site | Billings | Montana | 59101 | — |
| Pfizer Investigational Site | Albuquerque | New Mexico | 87106 | — |
| Pfizer Investigational Site | Albuquerque | New Mexico | 87109 | — |
| Pfizer Investigational Site | Charlotte | North Carolina | 28203 | — |
| Pfizer Investigational Site | Charlotte | North Carolina | 28204 | — |
| Pfizer Investigational Site | Charlotte | North Carolina | 28211 | — |
| Pfizer Investigational Site | Charlotte | North Carolina | 28262 | — |
| Pfizer Investigational Site | Charlotte | North Carolina | 28277 | — |
| Pfizer Investigational Site | Norman | Oklahoma | 73071 | — |
| Pfizer Investigational Site | Oklahoma City | Oklahoma | 73120 | — |
| Pfizer Investigational Site | Tulsa | Oklahoma | 74104 | — |
| Pfizer Investigational Site | Tulsa | Oklahoma | 74133 | — |
| Pfizer Investigational Site | Tulsa | Oklahoma | 74136 | — |
| Pfizer Investigational Site | Clairton | Pennsylvania | 15025 | — |
| Pfizer Investigational Site | Greensburg | Pennsylvania | 15601 | — |
| Pfizer Investigational Site | Pittsburgh | Pennsylvania | 15213 | — |
| Pfizer Investigational Site | Pittsburgh | Pennsylvania | 15232 | — |
| Pfizer Investigational Site | Pottstown | Pennsylvania | 19464 | — |
| Pfizer Investigational Site | Wexford | Pennsylvania | 15090 | — |
| Pfizer Investigational Site | Franklin | Tennessee | 37067 | — |
| Pfizer Investigational Site | Gallatin | Tennessee | 37066 | — |
| Pfizer Investigational Site | Hermitage | Tennessee | 37076 | — |
| Pfizer Investigational Site | Lebanon | Tennessee | 37087 | — |
| Pfizer Investigational Site | Memphis | Tennessee | 38120 | — |
| Pfizer Investigational Site | Murfreesboro | Tennessee | 37130 | — |
| Pfizer Investigational Site | Nashville | Tennessee | 37203 | — |
| Pfizer Investigational Site | Nashville | Tennessee | 37205 | — |
| Pfizer Investigational Site | Nashville | Tennessee | 37207 | — |
| Pfizer Investigational Site | Nashville | Tennessee | 37211 | — |
| Pfizer Investigational Site | Smyrna | Tennessee | 37167 | — |
| Pfizer Investigational Site | Austin | Texas | 78705 | — |
| Pfizer Investigational Site | Austin | Texas | 78745 | — |
| Pfizer Investigational Site | Austin | Texas | 78757 | — |
| Pfizer Investigational Site | Austin | Texas | 78759 | — |
| Pfizer Investigational Site | Beaumont | Texas | 77701 | — |
| Pfizer Investigational Site | Corpus Christi | Texas | 78405 | — |
| Pfizer Investigational Site | Corpus Christi | Texas | 78410 | — |
| Pfizer Investigational Site | Georgetown | Texas | 78626 | — |
| Pfizer Investigational Site | Bountiful | Utah | 84010 | — |
| Pfizer Investigational Site | Layton | Utah | 84041 | — |
| Pfizer Investigational Site | Murray | Utah | 84157 | — |
| Pfizer Investigational Site | Salt Lake City | Utah | 84102 | — |
| Pfizer Investigational Site | Salt Lake City | Utah | 84106 | — |
| Pfizer Investigational Site | West Provo | Utah | 84604 | — |
| Pfizer Investigational Site | West Valley City | Utah | 84120 | — |
| Pfizer Investigational Site | Richmond | Virginia | 23235 | — |
| Pfizer Investigational Site | Richmond | Virginia | 23298-0037 | — |
| Pfizer Investigational Site | Kennewick | Washington | 99336 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 90 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00435409, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 26, 2012 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00435409 live on ClinicalTrials.gov.